[Study on the incidence of Australia antigen in a controlled experiment of treatment with rifampicin].
D006511:Hepatitis B Antigens / Q000032:analysis; D006801:Humans; D007902:Length of Stay; D008099:Liver / Q000187:drug effects; D012293:Rifampin / Q000009:adverse effects / Q000627:therapeutic use*; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy* / Q000276:immunology
D006511:Hepatitis B Antigens; D012293:Rifampin
Rilievi sull'incidenza dell'A.Au in un esperimento controllato di trattamento con rifampicina